BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7748987)

  • 1. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.
    Anand A; Malison R; McDougle CJ; Price LH
    Biol Psychiatry; 1995 Mar; 37(5):338-40. PubMed ID: 7748987
    [No Abstract]   [Full Text] [Related]  

  • 2. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH; Dinan TG
    Biol Psychiatry; 1995 Mar; 37(6):364-8. PubMed ID: 7772644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.
    Murphy BE; Filipini D; Ghadirian AM
    J Psychiatry Neurosci; 1993 Nov; 18(5):209-13. PubMed ID: 8297920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoconazole therapy for atypical depression.
    Sovner R; Fogelman S
    J Clin Psychiatry; 1996 May; 57(5):227-8. PubMed ID: 8626356
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretical basis for response to steroid suppression in major depression.
    Rothschild AJ; Schatzberg AF
    J Clin Psychopharmacol; 1992 Apr; 12(2):142-4. PubMed ID: 1573041
    [No Abstract]   [Full Text] [Related]  

  • 6. Ketoconazole administration in hypercortisolemic depression.
    Wolkowitz OM; Reus VI; Manfredi F; Ingbar J; Brizendine L; Weingartner H
    Am J Psychiatry; 1993 May; 150(5):810-2. PubMed ID: 8480829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiglucocorticoid therapies in major depression: a review.
    Murphy BE
    Psychoneuroendocrinology; 1997; 22 Suppl 1():S125-32. PubMed ID: 9264159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemistry and paroxetine response in major depression.
    Goodnick PJ; Henry J; Kumar A
    Biol Psychiatry; 1995 Mar; 37(6):417-9. PubMed ID: 7772652
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman.
    Ravaris CL; Sateia MJ; Beroza KW; Noordsy DL; Brinck-Johnsen T
    Arch Gen Psychiatry; 1988 Oct; 45(10):966-7. PubMed ID: 3262333
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
    Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid functioning during treatment for depression.
    Kusalic M; Engelsmann F; Bradwejn J
    J Psychiatry Neurosci; 1993 Nov; 18(5):260-3. PubMed ID: 8297924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.
    McGrath PJ; Stewart JW; Quitkin FM; Wager S; Jenkins SW; Archibald DG; Stringfellow JC; Robinson DS
    J Clin Psychopharmacol; 1994 Oct; 14(5):347-52. PubMed ID: 7806692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
    Inoue T; Tsuchiya K; Miura J; Sakakibara S; Denda K; Kasahara T; Koyama T
    Biol Psychiatry; 1996 Jul; 40(2):151-3. PubMed ID: 8793048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K; Rybakowski J
    Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiglucocorticoid treatment of depression: double-blind ketoconazole.
    Wolkowitz OM; Reus VI; Chan T; Manfredi F; Raum W; Johnson R; Canick J
    Biol Psychiatry; 1999 Apr; 45(8):1070-4. PubMed ID: 10386195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression.
    Sonntag A; Rothe B; Guldner J; Yassouridis A; Holsboer F; Steiger A
    Depression; 1996; 4(1):1-13. PubMed ID: 9160649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.